MedTruth Editors
MedTruth Editors
Latest MedTruth Work by MedTruth Editors
Former Monsanto CEO Testifies in First R...
MedTruth Editors · May 20, 2022
This is the first trial in which former CEO of Monsanto Hugh Grant, who ran the company for 15 years, will testify.
Legal DevelopmentsFDA Warns About False NIPS Test Results
MedTruth Editors · May 19, 2022
NIPS tests work by taking a portion of the parent’s blood at a time when the fetal DNA can be detected. This DNA is examined for chromosomal or genetic abnormalities that may indicate future health problems.
Women's HealthCerebral Lawsuit Leads To ADHD Prescript...
MedTruth Editors · May 18, 2022
The lawsuit alleges that Cerebral’s business practices emphasized profits over patient safety and well-being.
News-
Former Monsanto CEO Testifies in First R...
MedTruth Editors · May 20, 2022
This is the first trial in which former CEO of Monsanto Hugh Grant, who ran the company for 15 years, will testify.
Legal Developments -
FDA Warns About False NIPS Test Results
MedTruth Editors · May 19, 2022
NIPS tests work by taking a portion of the parent’s blood at a time when the fetal DNA can be detected. This DNA is examined for chromosomal or genetic abnormalities that may indicate future health problems.
Women's Health -
Cerebral Lawsuit Leads To ADHD Prescript...
MedTruth Editors · May 18, 2022
The lawsuit alleges that Cerebral’s business practices emphasized profits over patient safety and well-being.
News
Opioid Settlement Increased by $46 Million
MedTruth Editors · May 17, 2022
Washington state's attorney general has secured a $518 million settlement from opioid manufactures.
Legal DevelopmentsWalgreens Opioid Lawsuit Settled For $683 Million
MedTruth Editors · May 11, 2022
The state of Florida has reached a settlement with Walgreens over the drug store’s alleged role in contributing to the opioid epidemic.
Legal DevelopmentsFDA Approves Marketing of New Alzheimer's Test
MedTruth Editors · May 11, 2022
A new diagnostic test for Azlheimer's detection has been FDA-approved for marketing.
FDA RegulationVeteran Awarded $2.2 Million in 3M Earplug Trial
MedTruth Editors · May 10, 2022
This is 3M's ninth trial loss in 15 bellwether trials alleging that defective military earplugs cause hearing damage and tinnitus.
Legal DevelopmentsStudy Finds Limited PFAS Levels in Face Masks
MedTruth Editors · May 9, 2022
Researchers found eight of the nine masks tested did not exceed safe PFAS exposure levels.
Research + FindingsEthicon Loses $300 Million Surgical Mesh Appeal
MedTruth Editors · May 6, 2022
The company must pay over $300 million to California for misleading marketing practices regarding transvaginal mesh products.
Legal DevelopmentsGet our reporting in your inbox
FDA Proposes Flavored Tobacco Products Ban
MedTruth Editors · May 5, 2022
These bans have the potential to significantly decrease the rates of disease and death caused by burned tobacco products.
FDA RegulationBay Area Cities Sue Monsanto Over PCB Cleanup Costs
MedTruth Editors · May 4, 2022
Monsanto allegedly knew about the environmental and health hazards of PCBs but hid this information for its own profit.
NewsFake Covid Drug Manufacturers Face FDA Action
MedTruth Editors · May 3, 2022
These latest actions are part of a continued effort to crack down on unapproved, untested, or ineffective treatments for Covid-19 being sold to consumers.
FDA RegulationEPA Proposes Final Asbestos Ban
MedTruth Editors · April 29, 2022
The proposal would ban the importation of the last type of asbestos currently able to be brought into the US.
NewsFDA Proposes New Opioid Safety Initiative
MedTruth Editors · April 28, 2022
This new initiative would provide another avenue to traditional opioid disposal methods.
FDA RegulationRoundup Judge Criticizes Proposed False Advertising Settlement
MedTruth Editors · April 27, 2022
The settlement would provide payments to consumers who purchased certain Roundup products and resolve a lawsuit claiming that Monsanto failed to warn users.
Legal DevelopmentsFDA Authorizes First COVID-19 Breath Test
MedTruth Editors · April 26, 2022
This breath test provides highly accurate COVID-19 test results in a shorter timeframe than traditional PCR tests.
NewsJudge Denies 3M’s Fee Acceleration Motion For Earplug Plaintiffs
MedTruth Editors · April 22, 2022
3M argued that a court decision that waived the administrative docket’s $402 per claim filing fee has ballooned the number of defective earplug claims.
Legal DevelopmentsFDA Issues Cybersecurity Guidance For Medical Devices
MedTruth Editors · April 21, 2022
Attacks from cybercriminals have rendered entire hospital networks powerless and have led to delays in diagnosis, delays in treatment, and increases in patient harm.
FDA RegulationBayer Settles Dozens of Roundup Cancer Claims
MedTruth Editors · April 20, 2022
In March, Bayer announced that of approximately 138,000 cancer claims filed by individuals, 107,000 had been resolved or deemed ineligible.
Legal DevelopmentsOpioid MDL Growth Halted
MedTruth Editors · April 19, 2022
The window to join the massive MDL in Northern Ohio has been officially closed by the JPML.
Legal DevelopmentsSandoz Recalls Potentially Carcinogenic Muscle Pain Pills
MedTruth Editors · April 15, 2022
The recall affects 13 lots of the muscle pain and spasm drug Orphenadrine Citrate.
NewsFDA Rescinds Covid Drug Authorization
MedTruth Editors · April 14, 2022
Sotrovimab is an intravenous monoclonal antibody medication originally authorized for treating Covid-19.
FDA RegulationJudge Grants Fast-Track Appeal of J&J’s Talc Bankruptcy
MedTruth Editors · April 13, 2022
Judge Kaplan allowed plaintiffs who have alleged that J&J’s asbestos-contaminated talc products caused them to develop cancer to appeal his ruling
Legal DevelopmentsFDA Issues Warning to Unauthorized COVID Drug Makers
MedTruth Editors · April 12, 2022
Two companies that claim to make drugs that cure Covid-19 have been sent FDA warning letters.
FDA Regulation13th Military Earplug Trial Returns $50 Million Plaintiff Verdict
MedTruth Editors · April 8, 2022
The trial concluded that the military veteran developed hearing loss and severe tinnitus because of 3M’s negligence.
Legal DevelopmentsFDA Issues Rulings on E-Cigarette Products
MedTruth Editors · April 7, 2022
The FDA has been reviewing millions of E-cigarette products, approving ones that are likely to assist adult smokers looking to reduce or eliminate their combustible cigarette use.
FDA RegulationPfizer Recalls Blood Pressure Drug
MedTruth Editors · April 6, 2022
Pfizer detected a potentially carcinogenic compound in the blood pressure lowering drug Accuretic.
NewsAcrylamide Lawsuits Halted Over Inconclusive Cancer Claims
MedTruth Editors · March 31, 2022
The federal court ruled that there is not enough evidence proving that acrylamide, a substance that’s formed during the heating process of certain foods, causes cancer.
NewsBayer Brings Second Roundup Verdict Petition to Supreme Court
MedTruth Editors · March 30, 2022
The company behind Roundup weedkiller, which thousands claim caused their cancer, is petitioning the nation’s high court to review a Roundup case for the second time.
Legal DevelopmentsFDA Recalls Ventilators For Adhesive Defect
MedTruth Editors · March 29, 2022
Philips Respironics’ ventilators could stop functioning without warning or notification, potentially leading to patient deaths.
FDA RegulationLos Angeles Sues Monsanto Over PCBs in City Waterways
MedTruth Editors · March 25, 2022
Los Angeles is accusing Monsanto of failing to issue a warning to the city about the hazards PCBs.
NewsFDA Approves First Generic Version of Symbicort
MedTruth Editors · March 24, 2022
Generic drugs help to improve accessibility of affordable medicine. Generic Symbicort will provide greater options for treatment to those with asthma and COPD.
FDA RegulationJ&J Tested Asbestos On Inmates, Unsealed Docs Reveal
MedTruth Editors · March 23, 2022
The company hired a doctor to test the effects of asbestos on the inmates’ skin against the effects of talc.
NewsFDA Orders Phillips To Issue CPAP Warnings
MedTruth Editors · March 22, 2022
Some Philips CPAP and BiPAP machines use a foam that may break down and cause serious injury.
FDA RegulationSmith & Nephew Hip Implant MDL Claims Reduced
MedTruth Editors · March 18, 2022
Plaintiffs in the MDL all underwent hip resurfacing surgery with metal-on-metal implants.
Legal DevelopmentsJ&J Talc Bankruptcy Sparks Legislation Movement
MedTruth Editors · March 17, 2022
Attorneys and senators have come forth to suggest changes be made to the legislation surrounding bankruptcy law.
Laws + CongressChantix Carcinogen Class Action Dismissed
MedTruth Editors · March 16, 2022
The complaint accused Pfizer of misrepresenting the safety of the drug to consumers by failing to properly test Chantix despite warnings from regulators.
NewsNew Opioid Plan Increases Penalties for Sacklers
MedTruth Editors · March 15, 2022
A deal has been reached between the Sackler Family and the nine remaining states in the nationwide opioid settlement.
Legal DevelopmentsCook Medical IVC Filter Litigation Makes History in Indiana
MedTruth Editors · March 11, 2022
Retrievable IVC filters should be removed, but many are left in the body, and can cause bodily damage and pain.
NewsDrugmakers Lose Push to Pause Opioid Litigation
MedTruth Editors · March 10, 2022
Opioid litigation will continue after a judge rejected drug manufacturers' request for a pause.
Legal Developments3M Appeals First Military Earplug Trial Loss
MedTruth Editors · March 9, 2022
The company behind the military earplugs that allegedly cause hearing loss is urging the appeals court to bring an end to litigation.
Legal DevelopmentsBankruptcy Court Approves J&J Talc Case
MedTruth Editors · March 8, 2022
The judge is allowing Johnson & Johnson to move forward with the bankruptcy process for the company's new entity, LTL Management.
Legal DevelopmentsInvestors Predict 3M Financial Woes May Increase
MedTruth Editors · March 4, 2022
The current expected legal cost amounts to $33 billion. Analysts predict this number to be much higher for 3M.
NewsFDA Approves New Heart Disease Treatment
MedTruth Editors · March 3, 2022
This new heart medication adds another treatment option to reduce the risk of cardiovascular death and hospitalization due to heart failure.
FDA RegulationCA State Court Hears Zantac Lawsuits in October
MedTruth Editors · March 2, 2022
California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.
Legal DevelopmentsBaby Formula Recalled by FDA
MedTruth Editors · March 1, 2022
Baby formula from a Michigan facility may be contaminated and has the potential to cause disease in infants.
NewsFDA Approves Generic Dry Eye Drug
MedTruth Editors · February 28, 2022
A generic form of Restasis has been FDA-approved for those suffering from dry eye. The drug increases the production of tears.
NewsFDA Recalls Fraudulent Covid Tests
MedTruth Editors · February 25, 2022
Two Covid tests labeled as FDA-approved have been recalled. The FDA recommends retesting with an authorized test and reporting any false results.
FDA RegulationVA Hearing Loss Bill Would Reduce Red Tape for Treatment
MedTruth Editors · February 22, 2022
The veteran has to prove that their damaged hearing was sustained during active duty, but many vets receive diagnoses after they have been discharged.
NewsTeva Settles Opioid Claims in Texas
MedTruth Editors · February 21, 2022
Teva will pay Texas $150 million in installments over the next 15 years to settle claims for the company's alleged role in the opioid epidemic.
NewsFDA Approves Veklury For Covid-19
MedTruth Editors · February 18, 2022
The FDA has approved a generic form of Remdesivir for the treatment of Covid in non-hospitalized patients.
NewsFDA Requests Public Comment on Credibility of Medical Device Models
MedTruth Editors · February 17, 2022
The new guidance will be used to support medical devices in the submission processes for a number of FDA approvals and clearances.
FDA Regulation$10 Million Eye Damage Lawsuit Joins Elmiron MDL
MedTruth Editors · February 16, 2022
Plaintiffs who allege that their vision has been damaged because of the drug all used Elmiron for many years.
Legal DevelopmentsJudge Blocks Discovery Request in Zantac Lawsuit
MedTruth Editors · February 15, 2022
GlaxoSmithKline will not be able to subpoena documents from plaintiffs in the Zantac multidistrict litigation.
Legal DevelopmentsHernia Mesh Victims Move for MDL Consolidation
MedTruth Editors · February 11, 2022
Because the patients’ claims are nearly identical, it would be inefficient to have the same discovery processes repeated in multiple courts.
NewsOpioid Manufacturers Settle With Indigenous Tribes
MedTruth Editors · February 10, 2022
Indigenous tribes have reached a settlement with opioid manufacturers over their alleged role in the opioid crisis.
Legal Developments3M Blasted By $110 Million Military Earplug Verdict
MedTruth Editors · February 9, 2022
This award is the largest thus far in the largest federal mass tort in U.S. history.
Legal DevelopmentsJudge Declines To Decide Talc Committee’s Motions
MedTruth Editors · February 8, 2022
Judge Freda L. Wolfson has declined to decide issues arising from the bankruptcy of J&J’s subsidiary, LTL Management.
Legal DevelopmentsNew Mexico Receives $44 Million From J&J To Resolve Opioid Claims
MedTruth Editors · February 4, 2022
J&J will pay New Mexico for its role in fueling the opioid epidemic in the state.
NewsFDA Releases Patient Feedback Guidance
MedTruth Editors · February 3, 2022
The goal of these new guidances is to give patients and advocates a voice in the medical device process.
FDA RegulationSanofi Wins Taxotere Trial Over Hair Loss Claims
MedTruth Editors · February 2, 2022
Over 12,000 individuals allege that the breast cancer drug Taxotere caused their permanent hair loss, and that manufacturer Sanofi was aware that this could be a side effect of the drug.
Legal DevelopmentsFDA Recalls Medtronic Atherectomy Device
MedTruth Editors · February 1, 2022
Medtronic’s atherectomy system is a medical device used in surgical procedures to clear plaque from the walls of arteries that obstruct blood flow.
NewsRoundup Attorneys May Face Malpractice Claims For Failing to Produce Experts
MedTruth Editors · January 28, 2022
Judge Chhabria’s order stated that plaintiffs must produce an expert to support their claim that Roundup caused their non-Hodgkin's lymphoma.
Legal DevelopmentsFDA Recalls Anesthesia Component
MedTruth Editors · January 27, 2022
A flow anesthesia system provides inhaled anesthesia and controls the ventilation of patients with limited abilities to breathe.
NewsSupreme Court Asks Biden Admin To Weigh In on Roundup Appeal
MedTruth Editors · January 25, 2022
The U.S. Supreme Court asked the Solicitor General for the administration's views on the Roundup cancer trial that awarded plaintiff Edwin Hardeman $25 million.
Legal DevelopmentsFDA Releases Device Guidance Strategies For Women
MedTruth Editors · January 21, 2022
The CDRH Health of Women program aims to address the sex and gender disparity in medicine by including women in research and working to better understand their issues.
Women's HealthFDA-Approved COVID Testing Roundup
MedTruth Editors · January 20, 2022
The FDA has updated the Emergency Use Authorization clearance status of various different types of COVID-19 diagnostic tests.
FDA RegulationBayer Settles Boy's Roundup Rare Cancer Claims
MedTruth Editors · January 19, 2022
A mother claims her son developed Burkitt’s lymphoma from years of Roundup exposure.
Legal DevelopmentsDuPont Avoids PFAS Lawsuit in New York
MedTruth Editors · January 18, 2022
Suez Water New York claims DuPont contaminated New York’s water supply with PFAS.
Legal Developments3M Wins Ninth & Tenth Earplug Bellwether Trials
MedTruth Editors · January 14, 2022
The results of the latest 3M military earplug trials have gone in favor of manufacturer 3M, deeming the company not liable for two veterans' loss of hearing.
Legal DevelopmentsFDA Recalls Medtronic Ventilators After Complaints and Death
MedTruth Editors · January 13, 2022
The ventilators have an error that can cause the devices to stop working as intended and become inoperable, which can lead to neurological injury and, if left unchecked, death.
FDA RegulationPurdue Pharma Opioid Settlement Rejected By Judge
MedTruth Editors · January 12, 2022
Judge McMahon rejected the bankruptcy settlement plan that would have resolved thousands of opioid epidemic lawsuits against Purdue Pharma.
Legal DevelopmentsFDA Warns Medtronic Over Faulty Insulin Pumps
MedTruth Editors · January 11, 2022
In an inspection of Medtronic’s firm, the FDA found four major failures in the facility’s insulin pump manufacturing practices.
FDA RegulationE-Cigarette Direct Purchasers Fight Forced Arbitration
MedTruth Editors · January 6, 2022
The lawsuit alleges that Juul Labs sold a 35% share of its company to the Altria Group as part of a conspiracy to push Altria out of the e-cigarette marketplace in a bid for supremacy over e-cigarette prices.
Legal DevelopmentsArmy Vet Awarded $22.5 Million in 3M Combat Earplugs Trial
MedTruth Editors · January 5, 2022
A federal jury in Florida found that 3M’s Combat Arms Earplugs were responsible for the Army vet’s hearing damage.
Legal DevelopmentsEthicon Attorneys Accuse Plaintiffs of Concealing Materials
MedTruth Editors · January 4, 2022
Attorneys for Ethicon told a New Jersey federal court that it needs access to marketing documents used by several lead-generation companies for attorneys.
Legal DevelopmentsWhistleblower Lawsuit Dismissed for Confidentiality Breach
MedTruth Editors · January 3, 2022
Two doctors claimed that the metal-on-metal hip implants of DePuy and J&J that were sold fell outside the FDA-approved manufacturing specifications.
Legal DevelopmentsStates Urge Federal Judge To Reject Purdue Pharma Settlement
MedTruth Editors · December 16, 2021
A group of U.S. states is urging a federal judge to reject a settlement that may benefit Oxycontin maker Purdue Pharma.
Legal DevelopmentsJ&J Talc Lawsuit Transfer to NJ Opens Suit to Dismissal
MedTruth Editors · December 15, 2021
After being transferred to New Jersey in November, J&J’s bankruptcy case may now meet fiercer resistance.
Legal DevelopmentsPlaintiffs in JUUL Lawsuit Thrown Out by Federal Judge
MedTruth Editors · December 14, 2021
The judge has thrown out 19 plaintiffs suing Juul Labs for injuries and deceitful marketing.
Legal DevelopmentsP&G Old Spice & Secret Products Recalled Over Benzene
MedTruth Editors · December 13, 2021
Old Spice men’s cologne and Secret deodorant aerosol cans were found to have detectable levels of benzene, a known human carcinogen that may cause cancer.
NewsParagard MDL Proceeds to Discovery
MedTruth Editors · December 10, 2021
The Paragard case will be moving forward after overcoming a motion to dismiss.
Legal DevelopmentsCancer Researchers Criticize Glyphosate Approval in the EU
MedTruth Editors · December 9, 2021
Europe’s leading cancer researchers are questioning the EU's decision to issue a positive safety review for glyphosate.
Research + FindingsOhio Jury Finds Pharmacies Liable For Opioid Crisis
MedTruth Editors · December 7, 2021
This verdict comes as an upset to a streak of losses that counties have suffered across the nation.
Legal DevelopmentsCalifornia Couple’s $86 Million Roundup Award Refused Review
MedTruth Editors · December 6, 2021
Bayer petitioned to review the outcome of the third Roundup trial that resulted in a damage award of $86 million.
Legal DevelopmentsJohnson & Johnson Settles Most Risperdal Lawsuits
MedTruth Editors · December 3, 2021
Thousands of lawsuits alleged that Risperdal, an anti-psychotic medication, caused them to develop enlarged breast tissue.
Legal DevelopmentsBaby Formula Lawsuits Filed Against Enfamil and Similac
MedTruth Editors · December 2, 2021
Premature infants were fed baby formulas Enfamil and Similac may develop a serious condition known as necrotizing enterocolitis (NEC).
NewsArmy Vet Awarded $13 Million in 3M Earplug Trial
MedTruth Editors · November 30, 2021
Guillermo Camarillorazo, a sergeant who served in Iraq and Afghanistan, was awarded $13 million.
Legal DevelopmentsTalc Advocates Reject J&J Settlement Talks
MedTruth Editors · November 29, 2021
Johnson & Johnson will most likely have to wait until at least 2022 before it can restart to negotiate a resolution.
Legal DevelopmentsNursing Home Outbreak Kills 8, Infects Dozens
MedTruth Editors · November 23, 2021
In a COVID outbreak at a nursing home in Connecticut, only three residents avoided infection.
NewsSupreme Court Throws Out Opioid Verdict
MedTruth Editors · November 18, 2021
The case accused Johnson & Johnson of creating a public nuisance with their opioid marketing that contributed to the opioid crisis
Legal DevelopmentsJ&J Allegedly Delaying Talc Trial in Mississippi
MedTruth Editors · November 17, 2021
Mississippi's Attorney General urged the Supreme Court to reject J&J's petition to delay the state’s seven-year talcum powder lawsuit.
Legal DevelopmentsProblematic KY Nursing Homes Profited From Pandemic Relief
MedTruth Editors · November 16, 2021
In Kentucky, some nursing homes profited from the pandemic even as their level of care decreased.
NewsGiant Eagle Resolves Ohio Opioid Suit During Trial
MedTruth Editors · November 12, 2021
The company agreed to settle lawsuits that accuse it of contributing to the opioid crisis in communities throughout Ohio.
Legal DevelopmentsDefendants Move For Paraquat MDL Dismissals
MedTruth Editors · November 11, 2021
Corporations Syngenta and Chevron USA are attempting to weed out invalid claims from the MDL.
Legal DevelopmentsOK Legislature Considers Revising Strict Opioid Law
MedTruth Editors · November 9, 2021
Oklahoma may roll back a Senate Bill that limits initial opioid prescription terms.
Laws + CongressPhilips Faces Class Action Suit Over Recalled Sleep Apnea Device
MedTruth Editors · November 8, 2021
Philips' CPAP machine was recalled in June over concerns that users could be exposed to polyester foam.
Legal DevelopmentsFDA Greenlights the First E-Cigarette Products for Sale
MedTruth Editors · November 5, 2021
The FDA has has authorized the first e-cigarette on the market, and it's not JUUL.
FDA RegulationElmiron Science Day Educates Judicial Officers
MedTruth Editors · November 4, 2021
Judicial officers were briefed on the mechanisms of Elmiron’s interaction with patients and the effects of long-term exposure linked to vision damage.
Legal DevelopmentsJudge Approves Investor Roundup Lawsuit Against Bayer
MedTruth Editors · November 3, 2021
Bayer failed to disclose the financial risks associated with the company’s 2018 acquisition of the Monsanto Corporation to its shareholders.
Legal DevelopmentsCOVID Burnout Takes a Toll on Social Workers
MedTruth Editors · November 2, 2021
Social workers dealing with opioid overdoses face an extra source of stress coming from the ongoing pandemic.
Health FeaturesEPA Launches Pesticide Investigation Councils
MedTruth Editors · November 1, 2021
The OCSPP Science Policy Council will monitor issues that arise within the pollution, toxics and pesticide sectors.
NewsPharmacies Accuse Gilead of Impeding Generic Drug Release
MedTruth Editors · October 27, 2021
CVS and Rite Aid are suing Gilead for suppressing the release of generic HIV drugs.
Legal DevelopmentsPatients Continue to Use Opioids 3 Months After Procedures
MedTruth Editors · October 26, 2021
A study found that 21% of patients continued to refill their opioid prescription three months to a year following their procedure.
Research + FindingsOhio Nursing Home Surveillance Law Introduced
MedTruth Editors · October 25, 2021
The proposed law would allow surveillance instruments in nursing homes for patient protection.
Laws + CongressJ&J Wins Third Post-Pandemic Talc Powder Ovarian Cancer Trial
MedTruth Editors · October 22, 2021
This marks J&J’s third ovarian cancer talc trial win since cases were resumed after pandemic lockdowns.
Legal DevelopmentsBranded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsThe 510(k) Approval Process: A Guide
MedTruth Editors · October 19, 2021
Manufacturers can use the 510(k) process as long as their new medical device is appropriately similar to a device that has already been approved.
FDA RegulationPharmacy Employees Warned About Opioids
MedTruth Editors · October 18, 2021
Employees of major pharmacies may have tried to alert their superiors of suspicious opioid prescriptions.
NewsArmy Vet Awarded $8 Million in Combat Earplug Trial
MedTruth Editors · October 15, 2021
3M has lost its 3rd combat earplug trial and owes Army veteran Brandon Atkins over $8 million for his hearing issues.
Legal DevelopmentsCVS Executive Speaks Out in Opioid Trial
MedTruth Editors · October 14, 2021
Pharmacies have countered that they have robust opioid monitoring systems to prevent abuse by illegitimate prescriptions.
Legal DevelopmentsHow Many Types of PFAS Exist?
MedTruth Editors · October 12, 2021
While PFOA and PFOS have been well documented as harmful, many companies are switching to a new PFAS chemical: GenX.
Health FeaturesU.S. Nursing Homes Accused of Overprescribing Antipsychotic Medication
MedTruth Editors · October 8, 2021
Many nursing homes are falsely diagnosing their residents with schizophrenia.
NewsVaccine Adverse Event Reporting System: A Guide
MedTruth Editors · October 7, 2021
By understanding the benefits and limitations of VAERS, consumers can advocate for their health in a more informed way.
FDA RegulationPFAS Lawsuits Centered in Georgia Have National Implications
MedTruth Editors · October 6, 2021
Last week, a federal judge in Georgia issued a ruling on one of the cases that could affect PFAS litigation throughout the nation.
Legal DevelopmentsJ&J Cleared in PA Talc Trial
MedTruth Editors · October 5, 2021
A jury acquitted Johnson & Johnson of civil liability for one woman’s ovarian cancer.
Legal DevelopmentsChronically-Ill Roundup Plaintiff Struggles to Testify
MedTruth Editors · October 1, 2021
A woman who suffers from significant memory loss struggled to answer questions posed by a Monsanto attorney in a Roundup trial.
Legal DevelopmentsJudge Prevents Injunction Against J&J Asset Splitting
MedTruth Editors · September 30, 2021
The plaintiffs argue that this financial maneuver would unlawfully shield Johnson & Johnson from any liability the company may owe for its talcum powder’s connection to ovarian cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsFlorida Compounding Pharmacy Punished by Federal Court
MedTruth Editors · September 28, 2021
The U.S. federal court has placed a permanent injunction prohibiting a Florida-based pharmaceutical company from producing or distributing any drugs.
FDA RegulationPremarket Approval Process: An Overview
MedTruth Editors · September 27, 2021
The Premarket Approval process reviews a device's medical effectiveness and design safety.
Health FeaturesJ&J Returns to Court In “Ground Zero” For Ovarian Cancer Lawsuits
MedTruth Editors · September 24, 2021
The first J&J talcum powder trial since before the pandemic has begun in Missouri over ovarian cancer claims.
Legal DevelopmentsLouisiana Department of Health Shuts Down Nursing Homes
MedTruth Editors · September 23, 2021
Nursing home residents were evacuated to a warehouse to shelter from Hurricane Ida in conditions deemed squalid.
NewsParaquat Claims Could Cost Syngenta & Chevron Billions
MedTruth Editors · September 22, 2021
Legal experts involved in paraquat litigation estimate that there may eventually be tens of thousands of cases.
Legal DevelopmentsFDA Spares JUUL From Market Dismissal
MedTruth Editors · September 21, 2021
The FDA's judgment on JUUL is in the final stages of review.
FDA RegulationSackler Family To Receive Broad Immunity in Purdue Settlement
MedTruth Editors · September 17, 2021
With the approval, the Sacklers will pay $4.5 billion from the family’s personal fortune over nine years and will relinquish control of the company to a government-run entity.
Legal DevelopmentsFDA Public Workshop To Standardize Opioid Education
MedTruth Editors · September 15, 2021
The FDA will conduct a workshop to review the education that opioid prescribers receive in an attempt to reduce the recreational use of opioids.
FDA RegulationMaine To Ban Products With PFAS Chemicals
MedTruth Editors · September 13, 2021
Maine’s law will forbid the sale of products with PFAS chemicals.
News$26 Billion Opioid Settlement Rejected By Five States
MedTruth Editors · September 10, 2021
Five states have rejected a deal with opioid drug distributors, and a few more states may follow suit.
Legal DevelopmentsNewly-Released Internal EPA Report Links Glyphosate to Cancer
MedTruth Editors · September 8, 2021
An internal EPA document from 2016 suggested that several studies reported elevated risks of non-Hodgkin's lymphoma associated with glyphosate exposure.
NewsStudy Finds Children Receiving High-Risk Opioid Prescriptions
MedTruth Editors · September 7, 2021
Researchers analyzed roughly four million opioid prescriptions dispensed to kids, teenagers, and young adults under age 21.
Research + FindingsFirst Bard Hernia Mesh Bellwether Trial Underway
MedTruth Editors · September 3, 2021
Over 13,000 lawsuits have been filed against C.R. Bard over defective hernia mesh claims.
Legal DevelopmentsJ&J Hit With $26.5 Million Talc Verdict
MedTruth Editors · September 2, 2021
Christina Prudencio's lawyer claimed her terminal mesothelioma was rooted in Johnson & Johnson ignoring decades of proof that their talcum products were unsafe.
Legal DevelopmentsJ&J Concealed Talc Risks To Preserve Brand Image, Philly Jury Told
MedTruth Editors · September 1, 2021
The plaintiff in a Philadelphia trial claimed J&J was aware that its baby powder was associated with cancer risk but withheld that information for decades in order to protect its brand image.
NewsBoston Scientific Recalls Pacemakers
MedTruth Editors · August 31, 2021
Boston Scientific has recalled a line of pacemakers in a Class I recall, which is issued for products which could cause serious injury or death.
NewsBayer Petitions Supreme Court To Review 2nd Roundup Trial
MedTruth Editors · August 30, 2021
Bayer filed a petition to reverse a verdict that awarded a Roundup user $80 million in damages.
Legal DevelopmentsEPA Bans Chlorpyrifos, Citing Neurological Concerns
MedTruth Editors · August 26, 2021
The EPA has banned chlorpyrifos, a pesticide used on crops since 1965.
NewsBankruptcy Judge To Consider $4 Billion Purdue Pharma Opioid Settlement
MedTruth Editors · August 25, 2021
Under the proposed bankruptcy plan, Purdue Pharma would be reorganized into a new entity.
Legal DevelopmentsGeorgia Ranked 49th in Nursing Home Inspection Rates
MedTruth Editors · August 24, 2021
Georgia regulator have failed to check on the safety and quality of nursing homes in the state.
NewsNorth Georgia Healthcare Center Settles Whistleblower Lawsuit
MedTruth Editors · August 19, 2021
The healthcare center agreed to pay the federal government $130,000 to settle a whistleblower lawsuit filed by a former employee.
Legal DevelopmentsZantac MDL Judge Reduces Relevant Defendants
MedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal DevelopmentsWashington State Executes Disciplinary Action on Long-Term Care Workers
MedTruth Editors · August 12, 2021
The Washington State Department of Health published a news release detailing the revocation, suspension, and decertification of a number of health care professionals.
NewsCalifornia Court Upholds J&J Talc Verdict
MedTruth Editors · August 10, 2021
On August 5, a California court rejected Johnson & Johnson’s appeal to exclude the testimony of an expert who found asbestos in talcum powder.
Legal DevelopmentsEPA Renews Paraquat Approval
MedTruth Editors · August 5, 2021
In the press statement confirming their decision to renew paraquat’s approval, the EPA included a number of new limitations on the way paraquat could be applied.
NewsTalc Lawsuit Accuses J&J of Targeting Black Women
MedTruth Editors · August 3, 2021
Attorneys claim Johnson & Johnson intentionally targeted black women with their baby powder advertisements.
NewsTexas Veterans Homes Called “Deadliest Places To Be”
MedTruth Editors · July 29, 2021
Texas veterans homes were some of the worst places to be in terms of COVID-19 infections and deaths.
NewsDrug Makers Agree to $26 Billion Nationwide Settlement To Resolve Opioid Suits
MedTruth Editors · July 26, 2021
Three drug distributors will pay $26 billion to resolve thousands of lawsuits filed over the opioid epidemic.
Legal DevelopmentsScottish Vaginal Mesh Victims Sent to the U.S.
MedTruth Editors · July 22, 2021
Scotland has agreed to pay for Scottish women implanted with vaginal mesh to travel to the United States and undergo treatment from a specialist.
Women's HealthJuul Settles Youth Vaping Marketing Lawsuit For $40 Million
MedTruth Editors · July 20, 2021
Juul Labs and North Carolina have reached a settlement in a lawsuit claiming Juul promoted vaping to youths.
Legal DevelopmentsPelvic Mesh Lawsuit Amendment Struck Down by Penn. Court
MedTruth Editors · July 14, 2021
Judge Wiegand has rejected the amended complaint of Susan and Carl Antonucci in an ongoing lawsuit regarding Boston Scientific’s pelvic mesh products.
Legal Developments15 States Sign on to Opioid Settlement
MedTruth Editors · July 12, 2021
Fifteen states have chosen to accept Purdue Pharmaceutical's $4.5 billion opioid settlement offer.
NewsSupreme Court Allows Johnson & Johnson's $2 Billion Baby Powder Cancer Verdict
MedTruth Editors · June 7, 2021
The Supreme Court has allowed a $2.1 billion baby powder cancer verdict against Johnson & Johnson to stand.
NewsNew York Restores Right to Sue Nursing Homes for COVID-19 Injuries and Deaths
MedTruth Editors · April 21, 2021
Governor Cuomo signed a bill repealing a New York law that protects health care facilities and professionals from COVID-19 related lawsuits.
Legal DevelopmentsMulti-Million Dollar Transvaginal Mesh Settlement with 47 States
MedTruth Editors · March 31, 2021
Boston Scientific has agreed to settle transvaginal mesh claims from 47 states and the District of Columbia for $188.7 million. Last week’s settlement concludes a series of lawsuits accusing Boston Scientific of violating consumer protection laws by misrepresenting the safety and effectiveness of their transvaginal mesh products.
Legal DevelopmentsNew Guide Teaches Consumers How to Verify FDA Approved Medical Products
MedTruth Editors · March 18, 2021
Following an increase in fake “FDA Registration Certificates,” the FDA published an online consumer guide to medical device approval.
FDA RegulationMedical Research Peer Review Process: What You Need to Know
MedTruth Editors · March 5, 2021
The medical peer review process is a crucial aspect of research. Biases and limitations of the process may lead to misleading or inaccurate studies.
Research + FindingsBreast Implant Dangers: Arizona Bill Would Improve Patient Information
MedTruth Editors · February 25, 2021
A bill intended to increase patient awareness of the dangers of breast implants was preliminarily approved in January.
Women's HealthMultidistrict Litigation: What You Need to Know
MedTruth Editors · February 5, 2021
A guide to multidistrict litigation, from the basics to the reasoning behind consolidating lawsuits.
Legal DevelopmentsSenators Demand Answers From FDA on Imported Drug Safety
MedTruth Editors · November 24, 2020
Senators Elizabeth Warren and Tina Smith have voiced concerns around reductions in FDA oversight of foreign drug manufacturing facilities.
FDA RegulationFDA Issues Guidance on Drug Impurities
MedTruth Editors · September 8, 2020
The FDA announced new guidance on Sept. 1 for drugmakers, citing “serious concerns” about common medications.
FDA RegulationParagard Lawsuit Claims Copper IUD Broke in Uterus
MedTruth Editors · September 3, 2020
A woman is suing the maker of the Paragard intrauterine device after part of the copper IUD broke off in her uterus during removal.
Women's HealthDrug Companies Investigated for Possible Failure to Disclose Zantac Cancer Risks
MedTruth Editors · September 1, 2020
The U.S. Department of Justice is investigating whether drugmakers violated the False Claims Act by possibly failing to disclose the presence of NDMA in their Zantac and generic ranitidine heartburn products.
NewsHigh BPA Linked to 49% Increased Risk of Death
MedTruth Editors · August 28, 2020
New research suggests BPA may be linked to a higher death rate from conditions including cardiovascular disease.
Research + FindingsEssure Settlement Costs Bayer $1.6 Billion
MedTruth Editors · August 20, 2020
Bayer will pay $1.6 billion to settle the majority of U.S. claims brought by women who said they were sickened or harmed by Essure permanent birth control.
Legal DevelopmentsExpanding FDA List of Potentially Toxic Hand Sanitizers Hits 77
MedTruth Editors · July 24, 2020
The list of hand sanitizers potentially contaminated with toxic methanol has continued to grow since the FDA first raised concerns in June.
FDA Regulation7 Films to Celebrate Pride 2020
MedTruth Editors · June 26, 2020
In the mood for a queer documentary, comedy or romance? Look no further. We've selected a handful of the best gay, lesbian and trans films to watch during Pride 2020 and all year long.
Health FeaturesFilm & Guide: How to Report Adverse Events to the FDA
MedTruth Editors · June 24, 2020
Adverse event reporting is essential to patient safety. Watch our short film and download the MedTruth Guide to Adverse Event Reporting to help you prepare to share your side effects with the FDA.
Health FeaturesCanadian Drug Co. Apotex Recalls Metformin Due to NDMA Contamination
MedTruth Editors · May 29, 2020
Metformin was voluntarily recalled after N-Nitrosodimethylamine (NDMA) was discovered in a single lot of Apotex’s product.
FDA RegulationMT Weekly: COVID-19 Testing Accuracy, Organ Failure, Plasma Therapy
MedTruth Editors · May 14, 2020
This week, MedTruth summarizes key info about COVID-19 testing efficacy. Plus, nursing home testing, a large-scale hydroxychloroquine study and a promising new plasma therapy for coronavirus patients.
NewsMT Weekly: New COVID-19 Symptoms, Multi-Million Dollar Mesh Settlement
MedTruth Editors · May 7, 2020
This week, MedTruth relays new COVID-19 symptoms and a quick and cheap diagnostic test in the works. Plus, FDA warnings to companies selling “fraudulent” COVID-19 products and a 3.9 million pelvic mesh lawsuit.
NewsMT Weekly: Emergency Approval for COVID Drug, Nursing Homes Request National Protections
MedTruth Editors · May 1, 2020
This week, MedTruth summarizes key info about the emergency COVID-19 drug remdesivir. Plus, nursing home immunity, a breakdown of the Daubert opinion and a clinical trial hoping to deliver a vaccine by the end of the year.
NewsMT Weekly: Trump Orders Ventilator Production, Coronavirus May Spread From Talking
MedTruth Editors · April 2, 2020
MedTruth is focusing on the coronavirus. Here’s a summary of the most important public health developments this week.
NewsMT Weekly: Major COVID-19 Developments
MedTruth Editors · March 26, 2020
This week, MedTruth is focusing on the coronavirus. Here’s a summary of key developments from regulatory agencies and justice department officials regarding COVID-19.
News4 Entertaining Health Films to Watch During Coronavirus Crisis
MedTruth Editors · March 20, 2020
As COVID-19 progresses and states begin to shelter-in-place, people are searching for movies to watch. From 'Thank You For Smoking' to 'Five Feet Apart,' here are a few Hollywood films depicting interesting, relevant public health concepts to keep you thinking and entertained.
Health FeaturesBlack History Month 2020: Honoring Leaders in Health and Medicine
MedTruth Editors · February 25, 2020
In honor of Black History Month 2020, MedTruth is highlighting the contributions of five Black Americans in the healthcare field.
Health FeaturesChronicon, First-Ever Chronic Illness Conference, Comes to New York
MedTruth Editors · October 9, 2019
On October 28, medical professionals and social influencers will gather to bring visibility to the topic of chronic illness. As one of the most prevalent health conditions the U.S. population, the event is a long-anticipated one. The first-ever chronic illness event, spearheaded by chronic illness advocated Nitika Chopra, is bound to be illuminating and inclusive for all who will be in attendance.
News